California Public Employees Retirement System Cyma Bay Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$135 Billion
Q2 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.94 - $4.92 $562,632 - $702,576	-142,800 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$4.23 - $6.55 $55,687 - $86,230	-13,165 Reduced 8.44%	142,800 $648,000
Q4 2020 Feb 02, 2021	SELL	$5.73 - $9.03 $16,617 - $26,186	-2,900 Reduced 1.83%	155,965 $895,000
Q3 2020 Nov 05, 2020	BUY	$3.32 - $7.24 $18,260 - $39,820	5,500 Added 3.59%	158,865 $1.15 Million
Q2 2020 Aug 12, 2020	BUY	$1.41 - $4.25 $80,320 - $242,101	56,965 Added 59.09%	153,365 $535,000
Q4 2019 Jan 27, 2020	BUY	$1.33 - $5.93 $100,814 - $449,494	75,800 Added 367.96%	96,400 $189,000
Q3 2019 Oct 31, 2019	BUY	$5.12 - $7.21 $5,027 - $7,080	982 Added 5.01%	20,600 $105,000
Q2 2019 Aug 15, 2019	BUY	$6.05 - $13.66 $118,688 - $267,981	19,618 New	19,618 $140,000
Q1 2019 May 03, 2019	SELL	$8.16 - $13.42 $375,588 - $617,695	-46,028 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$6.54 - $11.74 $54,883 - $98,522	-8,392 Reduced 15.42%	46,028 $362,000
Q3 2018 Nov 13, 2018	BUY	$10.88 - $14.52 $592,089 - $790,178	54,420 New	54,420 $603,000
Q2 2018 Aug 15, 2018	SELL	$10.66 - $14.38 $395,443 - $533,440	-37,096 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$9.0 - $15.16 $142,524 - $240,073	-15,836 Reduced 29.92%	37,096 $482,000
Q4 2017 Feb 06, 2018	BUY	$7.67 - $9.31 $405,988 - $492,796	52,932	52,932 $487,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account